This overview of systematic reviews looked at studies on Shuxuetong injection for people with ischemic stroke. The review did not report the number of people studied or where the studies took place. The main findings were that the injection showed variable effectiveness in improving neurological deficits and activities of daily living, and in normalizing some blood and lab parameters. The safety profile was favorable, with no significant increase in adverse events reported.
However, the certainty of the evidence was low or very low for most outcomes. The methodological quality of the included reviews was critically low, with a high risk of bias across all reviews. This means the findings are not reliable enough to guide treatment decisions.
The main reason to be careful is that the evidence is weak and uncertain. The review suggests future research should be rigorously improved to increase confidence in conclusions. Readers should understand that this does not confirm the injection works, and more high-quality studies are needed.